In this study, β-amyloid precursor protein (APP) and presenilin-1 (PS1) double-transgenic mice, which co-express five familial AD mutations (5XFAD) and rapidly recapitulate major features of AD pathology, were used to evaluate the therapeutic effects and mechanisms of action of triptolide on AD. This evidence concerns the gene APP and Alzheimer disease.